Axiom Investment Management’s GSK GSK Stock Holding History

Axiom Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.9K	Sell	1,200 -240	-17%	-$12.7K	0.04%	198
2026 Q1	$79.5K	Buy	+1,440	New	+$78K	0.06%	164
2022 Q4	–	Sell	-800	Closed	-$24K	–	222
2022 Q3	$24K	Sell	800 -4,800	-86%	-$182K	0.05%	217
2022 Q2	$308K	Buy	+5,600	New	+$309K	0.89%	44
2022 Q1	–	Sell	-6,077	Closed	-$336K	–	119
2021 Q4	$336K	Sell	6,077 -12,100	-67%	-$629K	0.33%	80
2021 Q3	$868K	Buy	+18,177	New	+$913K	0.87%	27
2019 Q3	–	Sell	-15,264	Closed	-$760K	–	307
2019 Q2	$760K	Sell	15,264 -743	-5%	-$37.3K	0.14%	166
2019 Q1	$836K	Sell	16,007 -351	-2%	-$17.5K	0.16%	153
2018 Q4	$781K	Buy	+16,358	New	+$806K	0.16%	142

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Axiom Investment Management's GSK Position: Q2 2026 in Review

Axiom Investment Management reduced its GSK (GSK) stake by 17% in Q2 2026, selling an estimated $12.7K and leaving 1,200 shares worth $62.9K. The position accounts for 0.04% of the portfolio, ranked #198.

Axiom Investment Management first reported a position in GSK in Q4 2018 and has held it in 9 quarters since. The position peaked at $868K in Q3 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Axiom Investment Management held 1,200 shares of GSK worth $62.9K as of Q2 2026.
Axiom Investment Management sold 240 GSK shares in Q2 2026, an estimated $12.7K.
GSK made up 0.04% of Axiom Investment Management's portfolio in Q2 2026, its #198 holding.
Axiom Investment Management first reported a position in GSK in Q4 2018 and has held it in 9 quarters since.
Axiom Investment Management's GSK position peaked at $868K in Q3 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.